tiprankstipranks
Trending News
More News >
Bal Pharma Limited (IN:BALPHARMA)
:BALPHARMA
India Market

Bal Pharma Limited (BALPHARMA) Income Statement

Compare
0 Followers

Bal Pharma Limited Income Statement

Last quarter (Q1 2026), Bal Pharma Limited's total revenue was ₹658.71M, a decrease of -11.41% from the same quarter last year. In Q1, Bal Pharma Limited's net income was ₹2.01M. See Bal Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 3.03B₹ 3.39B₹ 3.04B₹ 2.81B₹ 2.47B
Gross Profit
₹ 730.18M₹ 770.20M₹ 1.25B₹ 1.11B₹ 993.03M
Operating Expenses
₹ 396.01M₹ 396.65M₹ 1.08B₹ 967.88M₹ 457.34M
Depreciation and Amortization
₹ 97.71M₹ 100.71M₹ 91.28M₹ 90.40M₹ 95.21M
EBITDA
₹ 317.63M₹ 320.23M₹ 245.00M₹ 239.71M₹ 257.82M
Operating Income
₹ 197.89M₹ 214.57M₹ 177.23M₹ 149.18M₹ 140.64M
Other Income/Expenses
₹ 0.00₹ 0.00₹ 0.00₹ -57.35M₹ 0.00
Pretax Income
₹ 51.38M₹ 90.47M₹ 47.48M₹ 91.83M₹ 41.03M
Net Income
₹ 72.15M₹ 73.92M₹ 25.72M₹ 56.12M₹ 47.42M
Per Share Metrics
Basic EPS
₹ 4.56₹ 4.70₹ 1.64₹ 3.79₹ 3.34
Diluted EPS
₹ 4.56₹ 4.68₹ 1.64₹ 3.79₹ 3.34
Weighted Average Shares Outstanding
14.58M 14.96M 15.69M 14.82M 14.20M
Weighted Average Shares Outstanding (Diluted)
14.58M 15.80M 15.69M 15.14M 14.20M
Currency in INR

Bal Pharma Limited Earnings and Revenue History